SS-31 (elamipretide) is one of the most targeted mitochondrial peptides in preclinical research because it does something remarkable: it binds directly to cardiolipin, a rare phospholipid that exists almost exclusively in the inner mitochondrial membrane. This article explains cardiolipin biology, why it matters for energy production, and how SS-31 uses this lipid to stabilize cellular energy.
Cardiolipin (also called diphosphatidylglycerol, or CL) is an unusual phospholipid found in the inner mitochondrial membrane. Unlike most cell membrane lipids, cardiolipin carries four negative charges at physiological pH — making it exceptionally anionic (negatively charged). This unique chemistry is the key to its function.
Structure: Four fatty acid chains, two phosphate groups, and a central glycerol backbone — much larger than typical membrane lipids. This size and charge distribution give it specialized roles.
Distribution: Cardiolipin comprises only 10–20% of inner mitochondrial membrane lipids by mass but is enriched in the regions where the electron-transport chain complexes sit. It is virtually absent from other cellular membranes.
Cardiolipin plays a central role in three critical mitochondrial functions:
1. Bioenergetics (ATP production)
Cardiolipin is essential for assembling and stabilizing the protein complexes of the electron-transport chain (Complex I, II, III, IV, and ATP synthase). Without proper cardiolipin concentration or structure, these complexes cannot form stable supercomplexes, and ATP production drops dramatically. Research shows that cardiolipin loss or oxidation is one of the earliest signs of mitochondrial dysfunction in aging and disease.
2. Apoptosis (cell death signaling)
Oxidized or depleted cardiolipin triggers the release of cytochrome c from the mitochondria, initiating the apoptotic cascade. This is a double-edged sword: controlled apoptosis eliminates damaged cells, but excessive cardiolipin damage can trigger cell death that researchers want to prevent.
3. Mitophagy (selective autophagy)
Cardiolipin modifications act as an "eat me" signal that marks damaged mitochondria for autophagy (cell cleanup). Proper cardiolipin chemistry ensures only truly defective mitochondria are removed.
SS-31 (Bendavia, MTP-131) is a small, water-soluble tetrapeptide (4 amino acids) designed to preferentially accumulate in mitochondria and bind cardiolipin. Here is how it works:
Mitochondrial targeting: SS-31 is positively charged (polybasic — rich in lysine and arginine). The large negative charge across the inner mitochondrial membrane — created by the proton gradient during energy production — pulls SS-31 inward like a magnet. Once inside, SS-31 concentrations can be 1,000–10,000× higher than in the cytoplasm.
Cardiolipin binding: Inside the membrane, SS-31's amphipathic structure (part hydrophobic, part hydrophilic) allows it to partition into the lipid interface where cardiolipin sits. The positive charges on SS-31 align with cardiolipin's negative charges, forming a stable complex.
Mechanism of stabilization: By binding to cardiolipin, SS-31 appears to:
Studies have investigated SS-31 in models of:
The most extensively studied application involves ischemia-reperfusion injury — the paradoxical damage that occurs when blood is restored to tissue after a stroke or heart attack. SS-31's ability to prevent cardiolipin-mediated cell death in this window appears to protect both cardiac and neural tissue.
SS-31 received FDA approval in December 2024 for Barth syndrome (a genetic mitochondrial disorder), marking the first mitochondrial-targeted peptide to reach an approved indication. However, for research use, SS-31 remains a powerful investigational tool for studying cardiolipin biology and mitochondrial energy metabolism in disease models.
Universe Peptide supplies SS-31 (product p009) for research into mitochondrial function and cardiolipin biology. Research-grade, HPLC-verified. See more in our News & research updates.